J.P. Morgan Downgrades Healthcare Realty Trust Inc(HR.US) to Hold Rating, Raises Target Price to $19
Healthcare Realty Trust Analyst Ratings
JP Morgan Downgrades Healthcare Realty Trust to Neutral, Announces $19 Price Target
Wells Fargo Maintains Healthcare Realty Trust Inc(HR.US) With Sell Rating, Announces Target Price $17
Wells Fargo Maintains Healthcare Realty Trust Inc(HR.US) With Sell Rating
Jefferies Maintains Healthcare Realty Trust Inc(HR.US) With Buy Rating, Cuts Target Price to $19
Scotiabank Maintains Healthcare Realty Trust Inc(HR.US) With Hold Rating, Maintains Target Price $18
BMO Capital Maintains Healthcare Realty Trust Inc(HR.US) With Hold Rating, Raises Target Price to $19
Scotiabank Maintains Healthcare Realty Trust Inc(HR.US) With Hold Rating, Raises Target Price to $18
BMO Capital Maintains Healthcare Realty Trust Inc(HR.US) With Hold Rating, Maintains Target Price $18.5
Wells Fargo Maintains Healthcare Realty Trust Inc(HR.US) With Sell Rating, Raises Target Price to $17
Healthcare Realty Trust Price Target Raised to $18.00/Share From $17.00 by Scotiabank
Healthcare Realty Trust Analyst Ratings
Jefferies Maintains Healthcare Realty Trust Inc(HR.US) With Buy Rating, Raises Target Price to $20
Healthcare Realty Trust Analyst Ratings
Wedbush Maintains Neutral on Healthcare Realty Trust, Raises Price Target to $18
BMO Capital Maintains Healthcare Realty Trust Inc(HR.US) With Hold Rating, Raises Target Price to $18.5
Healthcare Realty Trust Price Target Cut to $16.00/Share From $17.00 by Wells Fargo
Healthcare Realty Trust Analyst Ratings
Wells Fargo Downgrades Healthcare Realty Trust to Underweight, Lowers Price Target to $16